Clin2
NCT04457076Possibly a fitNot yet recruiting

Study of a new hormone-releasing IUD for birth control

ContraceptionWomen at Risk for Pregnancy

Part of Women’s health & pregnancy clinical trials.

This study tests a new type of intrauterine device (IUD) called LevoCept that releases a hormone to prevent pregnancy. The goal is to see how well it works, how safe it is, and whether it is comfortable for you.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 3
Enrollment
1,525 people
Ages
Up to 45 years
Study type
Interventional

Who can take part

  • You must be a woman between 18 and 45 years old (or under 18 with parental consent) and have regular menstrual cycles.
  • You must be sexually active with a male partner and willing to use the IUD as your only birth control method.
  • You must be in a monogamous relationship for at least 3 months.
  • You must have had a normal Pap test or an acceptable result within recommended guidelines.
  • You must not have any condition that could complicate IUD placement, such as certain uterine abnormalities or active infections.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT05444582Recruiting· Phase 4
52 mg hormonal IUD placed for emergency or same-day birth control

This study checks whether placing a 52 mg hormonal IUD soon after sex (up to 5 days) or on the same day (under certain timing) is safe and works as birth control. You may be able to join if you need emergency contraception or want to start an IUD right away and meet clinic and pregnancy-safety checks.

San Jose, California
NCT05702281Recruiting
Testing a new tool to place a copper IUD

This study tests whether a new inserter tool is safe and works well for placing a copper IUD called GYNEFIX. You may help researchers learn if the placement is easier and the device stays properly in place over 3 years.

Ghent
NCT07365904Recruiting· Phase 2
Testing a new contraceptive patch for ovulation prevention

This trial tests a new contraceptive patch to see if it can prevent ovulation (the release of an egg). If you are a healthy woman looking for a non-hormonal birth control option, this study may be a good fit.

Berlin
NCT07714616Not yet recruiting· Phase 3
New birth control pill for women

This trial tests a new birth control pill with a lower dose of estrogen and a different type of progestin. It aims to see how well it prevents pregnancy and if it's safe for women to use.

NCT06127199Recruiting
Birth control ring study for women

This study tests a new vaginal ring for birth control. If you join, you will use the ring as your only method of preventing pregnancy for about 13 months.

Phoenix, Arizona
NCT05237141Recruiting· Phase 4
Etonogestrel implant for emergency contraception

This trial studies whether placing an etonogestrel hormonal implant can work as emergency contraception and prevent pregnancy. You may be a good candidate if you have regular periods and are not currently pregnant or trying to get pregnant.

Aurora, Colorado

Hear when a new Contraception trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.